Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: How novel?

OK, if you want to play games, let's actually take a look. Brian was appointed to the advisory baord, 8/5/05. Shareprice at the time was 14 cents. Brian resigned from the Advisory Board in Feb or Mar 2008 time frame (i'm going from memory there), the share price was trading in the 40 cent range. So actually, I'd say relatively, Brian was quite successful. Since his departure, under just the BOD and management's steward ship, the share price has tanked. nearly 70%.

With respect to Turley, I was commenting on his role as advisory board member, not BOD member or CEO. Why do you view him as a failure in that role. For that matter, why do you view him as a failure as CEO? If you look at his record in delivering return on investment, he was named CEO on 6/4/07 and the share price was 52 cents. When he left, it was 40 cents. His negative return is comparatively low compared to others, lol. He didn't execute on any M&A during his tenure, so he was doing what you wanted him to.

You seem pretty arbitrary and emotional in your judgements, rather than realistic and accurate. If you're talking about just those three years, then arguably, those were the BEST three years in PTSC's history.

Share
New Message
Please login to post a reply